comscore ‘Jeopardy!’ host Alex Trebek says he’s resumed chemotherapy | Honolulu Star-Advertiser
Every act of aloha counts. Click here to DONATE to the MAUI RELIEF Fund.
Top News

‘Jeopardy!’ host Alex Trebek says he’s resumed chemotherapy

Honolulu Star-Advertiser logo
Unlimited access to premium stories for as low as $12.95 /mo.
Get It Now
  • ASSOCIATED PRESS / May 5

    Alex Trebek said today that he has had a setback in his battle with pancreatic cancer and is undergoing chemotherapy again. He is seen here at the 46th annual Daytime Emmy Awards at the Pasadena Civic Center in Pasadena, Calif. in May.

NEW YORK >> “Jeopardy!” host Alex Trebek says he’s had a setback in his battle with pancreatic cancer and is undergoing chemotherapy again.

Trebek told ABC’s “Good Morning America” today that after a short period of optimism when he stopped chemotherapy, his “numbers shot up” and doctors ordered him back on the treatment.

The 79-year-old game show host announced in March that he had Stage 4 pancreatic cancer. But he hasn’t missed a day on the show, which tapes its episodes in advance.

Trebek said his goals for the summer were to get his strength and hair back, and his progress on both fronts was “dismal.”

Comments (3)

By participating in online discussions you acknowledge that you have agreed to the Terms of Service. An insightful discussion of ideas and viewpoints is encouraged, but comments must be civil and in good taste, with no personal attacks. If your comments are inappropriate, you may be banned from posting. Report comments if you believe they do not follow our guidelines.

Having trouble with comments? Learn more here.

Click here to view ongoing news coverage of the Maui wildfires. Sign up for our free e-newsletter to get the latest news delivered to your inbox. Download the Honolulu Star-Advertiser mobile app to stay on top of breaking news coverage.

Be the first to know
Get web push notifications from Star-Advertiser when the next breaking story happens — it's FREE! You just need a supported web browser.
Subscribe for this feature

Scroll Up